Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Schrieber

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Clinical and Experimental Rheumatology|April 1, 1986
Pathogenesis of systemic lupus erythematosusL Schrieber, J P Edmonds
Current Opinion in Rheumatology|February 1, 1991
Rheumatic manifestations of neoplasiaA C Schwarzer, L Schrieber
Clinical Rheumatology|September 1, 1988
Splenic and renal infarction in systemic lupus erythematosus: association with anti-cardiolipin antibodiesM H Arnold, L Schrieber
The Netherlands Journal of Medicine|January 1, 1984
Circulating immune complexes (CIC) in connective tissue diseases (CTD)L Schrieber, R N Maini
Clinical and Experimental Immunology|July 1, 1990
Effect of leukotriene B4 and prostaglandin E2 on the adhesion of lymphocytes to endothelial cellsS S To, L Schrieber
Current Opinion in Rheumatology|December 1, 1989
Rheumatic manifestations of neoplasiaA C Schwarzer, L Schrieber
Cellular Immunology|November 1, 1988
Anti-Ia monoclonal antibody (10-2.16) inhibits lymphocyte-high endothelial venule (HEV) interactionN Manolios, C Geczy, L Schrieber
The Medical Journal of Australia|March 6, 1982
Immunological factors in uveitisD Wakefield, L Schrieber, R Penny
Lupus|August 12, 2004
Validity of the disease repercussion profile in patients with systemic lupus erythematosusL Sharpe, F Denton, L Schrieber
Drugs|September 1, 1988
Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritisM Arnold, L Schrieber, P Brooks
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Clinical and Experimental Rheumatology|April 1, 1986
Pathogenesis of systemic lupus erythematosusL Schrieber, J P Edmonds
Current Opinion in Rheumatology|February 1, 1991
Rheumatic manifestations of neoplasiaA C Schwarzer, L Schrieber
Clinical Rheumatology|September 1, 1988
Splenic and renal infarction in systemic lupus erythematosus: association with anti-cardiolipin antibodiesM H Arnold, L Schrieber
The Netherlands Journal of Medicine|January 1, 1984
Circulating immune complexes (CIC) in connective tissue diseases (CTD)L Schrieber, R N Maini
Clinical and Experimental Immunology|July 1, 1990
Effect of leukotriene B4 and prostaglandin E2 on the adhesion of lymphocytes to endothelial cellsS S To, L Schrieber
Current Opinion in Rheumatology|December 1, 1989
Rheumatic manifestations of neoplasiaA C Schwarzer, L Schrieber
Cellular Immunology|November 1, 1988
Anti-Ia monoclonal antibody (10-2.16) inhibits lymphocyte-high endothelial venule (HEV) interactionN Manolios, C Geczy, L Schrieber
The Medical Journal of Australia|March 6, 1982
Immunological factors in uveitisD Wakefield, L Schrieber, R Penny
Lupus|August 12, 2004
Validity of the disease repercussion profile in patients with systemic lupus erythematosusL Sharpe, F Denton, L Schrieber
Drugs|September 1, 1988
Immunosuppressive drugs and corticosteroids in the treatment of rheumatoid arthritisM Arnold, L Schrieber, P Brooks
Pageof 7